Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

agilon health inc - AGL

AGL

Close Chg Chg %
0.95 0.04 4.57%

Open Market

0.99

+0.04 (4.57%)

Volume: 2.67M

Last Updated:

Jan 22, 2026, 3:39 PM EDT

Trade Now

Company Overview: agilon health inc - AGL

AGL Key Data

Open

$0.94

 Day Range

0.94 - 1.03

52 Week Range

0.51 - 6.08

 Market Cap

$393.85M

Shares Outstanding

414.58M

 Public Float

304.23M

Beta

0.06

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.78

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

5.19M

  

AGL Performance

1 Week
 
 -6.56%
 
1 Month
 
 29.76%
 
3 Months
 
 -1.73%
 
1 Year
 
 -73.60%
 
5 Years
 
 N/A
 

AGL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 17
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Agilon Health Inc - AGL

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.83B 2.71B 4.32B 6.06B
Sales Growth
+50.50% +47.70% +59.38% +40.41%
Cost of Goods Sold (COGS) incl D&A
1.77B 2.61B 4.26B 6.08B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
14.67M 13.77M 20.16M 24.46M
Depreciation
2.77M 4.07M 12.16M 12.20M
Amortization of Intangibles
11.90M 9.70M 8.00M 12.26M
COGS Growth
+55.72% +47.30% +63.34% +42.63%
Gross Income
61.87M 98.51M 53.63M (19.62M)
Gross Income Growth
-23.26% +59.23% -45.56% -136.59%
Gross Profit Margin
+3.37% +3.64% +1.24% -0.32%
2021 2022 2023 2024 5-year trend
SG&A Expense
442.96M 216.47M 285.57M 264.33M
Research & Development
- - - -
-
Other SG&A
442.96M 216.47M 285.57M 264.33M
SGA Growth
+222.64% -51.13% +31.92% -7.44%
Other Operating Expense
- - - -
-
Unusual Expense
12.86M 7.93M 188.00K 8.17M
EBIT after Unusual Expense
(393.95M) (125.89M) (232.13M) (292.13M)
Non Operating Income/Expense
(4.50M) 24.73M 44.33M 49.48M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - 16.49M 14.99M
-
Interest Expense
6.15M 4.53M 6.66M 6.18M
Interest Expense Growth
-24.45% -26.37% +47.14% -7.22%
Gross Interest Expense
6.15M 4.53M 6.66M 6.18M
Interest Capitalized
- - - -
-
Pretax Income
(404.60M) (105.69M) (194.46M) (248.83M)
Pretax Income Growth
-548.99% +73.88% -83.99% -27.96%
Pretax Margin
-22.07% -3.90% -4.51% -4.11%
Income Tax
886.00K 1.64M 791.00K 1.45M
Income Tax - Current - Domestic
1.29M 1.11M 1.50M (18.00K)
Income Tax - Current - Foreign
- - 893.00K 1.25M
-
Income Tax - Deferred - Domestic
(403.00K) 530.00K (1.47M) 357.00K
Income Tax - Deferred - Foreign
- - (134.00K) (142.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - 16.49M 14.99M
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(405.48M) (107.33M) (195.25M) (250.28M)
Minority Interest Expense
(300.00K) (311.00K) (207.00K) 50.00K
Net Income
(405.18M) (107.02M) (195.05M) (250.33M)
Net Income Growth
-541.03% +73.59% -82.26% -28.34%
Net Margin Growth
-22.10% -3.95% -4.52% -4.13%
Extraordinaries & Discontinued Operations
(1.78M) 465.00K (20.00M) (1.06M)
Discontinued Operations
(1.78M) 465.00K (20.00M) (1.06M)
Net Income After Extraordinaries
(406.96M) (106.55M) (215.05M) (251.39M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(406.96M) (106.55M) (215.05M) (251.39M)
EPS (Basic)
-1.0172 -0.2611 -0.5259 -0.6117
EPS (Basic) Growth
-394.27% +74.33% -101.42% -16.31%
Basic Shares Outstanding
400.10M 408.15M 408.92M 410.97M
EPS (Diluted)
-1.0172 -0.2611 -0.5259 -0.6117
EPS (Diluted) Growth
-394.27% +74.33% -101.42% -16.31%
Diluted Shares Outstanding
400.10M 408.15M 408.92M 410.97M
EBITDA
(366.42M) (104.19M) (211.78M) (259.49M)
EBITDA Growth
-760.67% +71.57% -103.27% -22.53%
EBITDA Margin
-19.98% -3.85% -4.91% -4.28%

Insider Actions for Agilon Health Inc - AGL

Date Name Shares Transaction Value
Apr 4, 2025 Steven J. Sell CEO & President; Director 906,781 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Steven J. Sell CEO & President; Director 865,385 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Jeffrey A. Schwaneke Chief Financial Officer 22,300 Open market or private purchase of non-derivative security Non-derivative transaction at $11.22 per share 250,206.00
Apr 4, 2025 Jeffrey A. Schwaneke Chief Financial Officer 1,130,552 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Jeffrey A. Schwaneke Chief Financial Officer 673,077 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Girish Venkatachaliah Chief Technology Officer 277,670 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Girish Venkatachaliah Chief Technology Officer 192,308 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Benjamin Shaker Chief Markets Officer 885,980 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Benjamin Shaker Chief Markets Officer 673,077 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Denise V. Zamore Chief Legal Officer 450,047 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Denise V. Zamore Chief Legal Officer 384,616 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Timothy Gertsch Chief Accounting Officer 119,035 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Timothy Gertsch Chief Accounting Officer 96,154 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Agilon Health Inc in the News